Curated dataset · n=51 verified deals · Not live market data · Scores are descriptive, not forecasts.

Network graph, deal flow, valuation matrix, and acquirer landscape.

Alydia Health→Organon (via Merck spinoff)

Acquisition · Cash · OGN · announced Mar 30, 2021

View in network
  1. Announced

    Mar 30, 2021

  2. Closed

    Jul 1, 2021

Economics

Cash

Up to $240M total ($215M upfront cash + $25M contingent milestone); Organon press release Mar 30, 2021

Target

Alydia Health

Maternal Health · Clinical / therapeutic

HQ Menlo Park, CA · Founded 2011

Medical device company focused on preventing maternal morbidity from postpartum hemorrhage (Jada System)

  • Organon.com - press release (Mar 30, 2021)
  • Business Wire - Merck acquisition on behalf of Organon spinoff
  • Crunchbase - crunchbase.com/organization/alydia-health

Acquirer

Organon (OGN)

Reproductive Health

HQ Jersey City, NJ

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

Jada System addresses postpartum hemorrhage — aligns with Organon's mission as global women's health leader; potential EU/global expansion

Evidence ladder

Dual-source corroborationValue disclosed
  1. Secondary (press / IR)

    Organon.com press release (Mar 30, 2021)

  2. Secondary (press / IR)

    Business Wire

  3. Primary (regulatory / filing)

    SEC EDGAR 8-K https://www.sec.gov/Archives/edgar/data/1821825/000119312521180652/d49288dex992.htm

    Open source

Limitations

  • Up to $240M total ($215M upfront cash + $25M contingent milestone); Organon press release Mar 30, 2021

Other verified deals by Organon

Acquirer program history not already listed as a valuation peer or adjacency row.

TargetAcquirerAnnouncedValueSector
Dermavant SciencesOrganonSep 18, 2024Dermatology
Forendo PharmaOrganonNov 11, 2021Reproductive Health

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — Alydia Health (Maternal Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v9 · updated 2026-09-20 · 3 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.